TapewireFind a company

person · Reporting owner

KELLEY JOHN J III

Disclosed activity across 2 companies

Tapewire entity
73014
SEC CIK
0001562224

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BEAZER HOMES USA INCBZH · Entity 5036DirectorNovember 17, 2025November 18, 2025
EQUIFAX INCEFX · Entity 3235EVP, Chief Legal OfficerFebruary 11, 2025February 13, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BEAZER HOMES USA INC

Report date November 17, 2025 · Filed November 18, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect23,116 Reported balance After 2025-11-17 transaction · row 1
1 source row

Row 1 · 2025-11-17 · Grant · Acquired 7,199 · Balance 23,116

F1: Restricted stock award scheduled to vest on the first anniversary of grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock award scheduled to vest on the first anniversary of grant date.

EQUIFAX INC

Report date February 11, 2025 · Filed February 13, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect15,175 Last balance in matching sequence After 2025-02-11 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2025-02-11 · Grant · Acquired 2,710 · Balance 17,202

F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Row 2 · 2025-02-11 · Tax withholding · Disposed 2,027 · Balance 15,175

F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Filing footnotes · ownership attribution and instrument terms

F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 17, 2025 Filed Nov 18, 2025 23:13 UTC BEAZER HOMES USA INC BZH · Entity 5036 GrantCommon Stock 7,199 $0.00 $0.00
Disclosure

SEC source: 0001562224-25-000005 · wk-form4_1763507594.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,116

F1 · shares: Restricted stock award scheduled to vest on the first anniversary of grant date.

Read SEC document
May 09, 2025 Filed May 12, 2025 20:52 UTC BEAZER HOMES USA INC BZH · Entity 5036 PurchaseCommon Stock 10,000 $21.50 $215,000.00
Disclosure

SEC source: 0000915840-25-000047 · wk-form4_1747083140.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,917

F1 · price: The price is the weighted average price of the aggregate number of shares that were purchased by the reporting person. These shares were purchased in multiple transactions at prices ranging from $21.33 to $21.71. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 21:14 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 2,027 $253.00 $512,831.00
Disclosure

SEC source: 0001225208-25-001650 · doc4.xml · nonDerivative · entry 2

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,175

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 21:14 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 2,710 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-001650 · doc4.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,202

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:15 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 10,322 $0.00 Strike: $252.90 $0.00
Disclosure

SEC source: 0001225208-25-001584 · doc4.xml · derivative · entry 2

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,322

Underlying: Common Stock · 10,322 shares

Expires 2035-02-10

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2026.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 21:15 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 3,213 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-001584 · doc4.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,492

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2028.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 21:45 UTC BEAZER HOMES USA INC BZH · Entity 5036 GrantNo securities are beneficially owned 5,051 $0.00 $0.00
Disclosure

SEC source: 0000915840-24-000105 · wk-form4_1732052692.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,917

F1 · shares: Restricted stock award scheduled to vest on the first anniversary of grant date.

Read SEC document
October 25, 2024 Filed Oct 29, 2024 20:09 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 1,000 $272.92 $272,920.00
Disclosure

SEC source: 0001225208-24-009537 · doc4.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,269

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 28, 2024 Filed Aug 29, 2024 20:08 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 803 $305.91 $245,644.85
Disclosure

SEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 6

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,259

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024.

F8 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $305.73 to $306.50, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 28, 2024 Filed Aug 29, 2024 20:08 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 729 $305.14 $222,447.64
Disclosure

SEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 5

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,062

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024.

F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $304.73 to $305.70, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 28, 2024 Filed Aug 29, 2024 20:08 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 593 $302.92 $179,629.60
Disclosure

SEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 4

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,791

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024.

F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $302.61 to $303.36, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 28, 2024 Filed Aug 29, 2024 20:08 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 484 $307.08 $148,624.93
Disclosure

SEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 3

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,384

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024.

F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $306.73 to $307.405, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 28, 2024 Filed Aug 29, 2024 20:08 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 300 $304.30 $91,291.17
Disclosure

SEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 2

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,868

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $303.735 to $304.62, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 28, 2024 Filed Aug 29, 2024 20:08 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 91 $300.43 $27,339.09
Disclosure

SEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,168

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $300.39 to $300.47, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
August 07, 2024 Filed Aug 8, 2024 21:14 UTC BEAZER HOMES USA INC BZH · Entity 5036 GrantNo securities are beneficially owned 866 $0.00 $0.00
Disclosure

SEC source: 0000915840-24-000059 · wk-form4_1723151640.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 866

F1 · shares: Restricted stock award scheduled to vest on the first anniversary of grant date.

Read SEC document
July 25, 2024 Filed Jul 30, 2024 00:32 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionStock Option/Right to Buy · Derivative 5,523 $0.00 Strike: $191.44 $0.00
Disclosure

SEC source: 0001225208-24-007618 · doc4.xml · derivative · entry 5

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,523 shares

Expires 2026-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested in three equal annual increments beginning 2/21/2021.

Read SEC document
July 25, 2024 Filed Jul 30, 2024 00:32 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionStock Option/Right to Buy · Derivative 4,378 $0.00 Strike: $175.48 $0.00
Disclosure

SEC source: 0001225208-24-007618 · doc4.xml · derivative · entry 4

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,378 shares

Expires 2026-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested in three equal annual increments beginning 2/21/2021.

Read SEC document
July 25, 2024 Filed Jul 30, 2024 00:32 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 8,210 $267.56 $2,196,667.60
Disclosure

SEC source: 0001225208-24-007618 · doc4.xml · nonDerivative · entry 3

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,259

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
July 25, 2024 Filed Jul 30, 2024 00:32 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionCommon Stock 4,378 $175.48 $768,251.44
Disclosure

SEC source: 0001225208-24-007618 · doc4.xml · nonDerivative · entry 2

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,469

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
July 25, 2024 Filed Jul 30, 2024 00:32 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionCommon Stock 5,523 $191.44 $1,057,323.12
Disclosure

SEC source: 0001225208-24-007618 · doc4.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,091

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:49 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 2,560 $255.78 $654,796.80
Disclosure

SEC source: 0001225208-24-002070 · doc4.xml · nonDerivative · entry 2

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,546

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 21:49 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 3,943 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002070 · doc4.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,106

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 09, 2024 Filed Feb 13, 2024 21:10 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 8,871 $0.00 Strike: $249.18 $0.00
Disclosure

SEC source: 0001225208-24-001934 · doc4.xml · derivative · entry 2

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,871

Underlying: Common Stock · 8,871 shares

Expires 2034-02-09

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025.

Read SEC document
February 09, 2024 Filed Feb 13, 2024 21:10 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 2,760 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-001934 · doc4.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,163

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 9, 2027.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 21:30 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 2,127 $209.22 $445,005.20
Disclosure

SEC source: 0001225208-23-010349 · doc4.xml · nonDerivative · entry 5

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,394

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $208.675 to $209.635, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 21:30 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 655 $208.16 $136,343.16
Disclosure

SEC source: 0001225208-23-010349 · doc4.xml · nonDerivative · entry 4

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,521

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $207.665 to $208.62, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 21:30 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 635 $206.97 $131,424.62
Disclosure

SEC source: 0001225208-23-010349 · doc4.xml · nonDerivative · entry 3

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,176

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $206.56 to $207.345, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 21:30 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 358 $209.88 $75,138.11
Disclosure

SEC source: 0001225208-23-010349 · doc4.xml · nonDerivative · entry 2

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,811

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $209.755 to $210.01, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 21:30 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 225 $205.31 $46,194.98
Disclosure

SEC source: 0001225208-23-010349 · doc4.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,169

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $204.94 to $205.65, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionStock Option/Right to Buy · Derivative 19,172 $0.00 Strike: $149.53 $0.00
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · derivative · entry 13

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,172 shares

Expires 2025-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionStock Option/Right to Buy · Derivative 15,899 $0.00 Strike: $138.45 $0.00
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · derivative · entry 12

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,899 shares

Expires 2025-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionStock Option/Right to Buy · Derivative 13,150 $0.00 Strike: $127.37 $0.00
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · derivative · entry 11

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,150 shares

Expires 2025-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 506 $201.56 $101,987.39
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 10

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,394

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F9 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $201.54 to $201.56, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 13,123 $200.97 $2,637,335.87
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 9

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,900

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F8 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $200.51 to $201.44, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 5,365 $199.91 $1,072,498.91
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 8

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,023

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $199.51 to $200.50, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 23,803 $198.96 $4,735,780.61
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 7

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,388

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $198.49 to $199.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 4,266 $198.27 $845,818.97
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 6

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,191

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $197.47 to $198.465, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 753 $196.88 $148,246.95
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 5

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,457

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $196.44 to $197.40, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 405 $195.35 $79,116.10
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 4

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,210

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $195.02 to $195.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionCommon Stock 19,172 $149.53 $2,866,789.16
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 3

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,615

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionCommon Stock 15,899 $138.45 $2,201,216.55
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 2

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,443

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:06 UTC EQUIFAX INC EFX · Entity 3235 Exercise / conversionCommon Stock 13,150 $127.37 $1,674,915.50
Disclosure

SEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,544

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 21:08 UTC EQUIFAX INC EFX · Entity 3235 Tax withholdingCommon Stock 2,930 $203.81 $597,163.30
Disclosure

SEC source: 0001225208-23-002660 · doc4.xml · nonDerivative · entry 2

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,358

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 21:08 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 4,567 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002660 · doc4.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,288

F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:13 UTC EQUIFAX INC EFX · Entity 3235 GrantStock Option/Right to Buy · Derivative 8,504 $0.00 Strike: $206.16 $0.00
Disclosure

SEC source: 0001225208-23-001887 · doc4.xml · derivative · entry 2

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,504

Underlying: Common Stock · 8,504 shares

Expires 2033-02-10

F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2024.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:13 UTC EQUIFAX INC EFX · Entity 3235 GrantCommon Stock 2,668 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-001887 · doc4.xml · nonDerivative · entry 1

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,721

F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2026.

F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 2,765 $166.98 $461,694.17
Disclosure

SEC source: 0001225208-22-011214 · doc4.xml · nonDerivative · entry 6

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,042

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/24/2022.

F8 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $166.32 to $167.27, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 2,540 $165.43 $420,184.07
Disclosure

SEC source: 0001225208-22-011214 · doc4.xml · nonDerivative · entry 5

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,807

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/24/2022.

F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $165.00 to $165.93, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 2,135 $164.59 $351,392.60
Disclosure

SEC source: 0001225208-22-011214 · doc4.xml · nonDerivative · entry 4

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,347

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/24/2022.

F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $163.955 to $164.85, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 20:12 UTC EQUIFAX INC EFX · Entity 3235 SaleCommon Stock 567 $167.69 $95,078.87
Disclosure

SEC source: 0001225208-22-011214 · doc4.xml · nonDerivative · entry 3

KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,482

F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/24/2022.

F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $167.43 to $167.92, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.